Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study-Reference-Cited by-同舟云学术

Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study

Author:

Kuo Yu‐Jui¹²,Sung Fung‐Chang³,Hsieh Po‐Fan⁴,Chang Hui‐Ping¹,Wu Kun‐Ling⁵,Wu Hsi‐Chin⁴^ORCID

Affiliation:

1. Department of Traditional Chinese Medicine Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation) Tainan Taiwan

2. Department of Applied Cosmetology National Tainan Junior College of Nursing Tainan Taiwan

3. Department of Health Services Administration China Medical University Taichung Taiwan

4. Department of Urology China Medical University Hospital, China Medical University Taichung Taiwan

5. Department of Family Medicine Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation) Tainan Taiwan

Funder

National Research Program for Biopharmaceuticals

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

Reference53 articles.

3. Prostate cancer in elderly men;Stangelberger A;Rev Urol,2008

4. BPH: epidemiology and comorbidities;McVary KT;Am J Manag Care,2006

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献